Marielena Gutt-Will

Marielena Gutt-Will
Inselspital, Universitätsspital Bern · Department of Neurosurgery

Doctor of Medicine

About

7
Publications
238
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
20
Citations
Education
September 2012 - September 2019
Universität Bern
Field of study
  • Medicine

Publications

Publications (7)
Article
Machine learning-based solutions rely heavily on the quality and quantity of the training data. In the medical domain, the main challenge is to acquire rich and diverse annotated datasets for training. We propose to decrease the annotation efforts and further diversify the dataset by introducing an annotation-efficient learning workflow. Instead of...
Article
Full-text available
Background: The COVID-19 pandemic has greatly increased the incidence and clinical importance of critical illness myopathy (CIM), because it is one of the most common complications of modern intensive care medicine. Current diagnostic criteria only allow diagnosis of CIM at an advanced stage, so that patients are at risk of being overlooked, espec...
Article
Full-text available
Towards computer-assisted neurosurgery, scene understanding algorithms for microscope video data are required. Previous work utilizes optical flow to extract spatiotemporal context from neurosurgical video sequences. However, to select an appropriate optical flow method, we need to analyze which algorithm yields the highest accuracy for the neurosu...
Article
Among the most challenging diagnostic issues in surgical neuropathology is the distinction between scant infiltration by diffuse gliomas and reactive gliosis. The best documented ancillary marker to establish a definitive diagnosis of glioma in this setting is the identification of hotspot mutations in the isocitrate dehydrogenase 1 and 2 (IDH1/IDH...
Article
Background: In contrast to isocitrate dehydrogenase (IDH) mutation analysis, which is homogenous within a given tumor, diagnostic errors in histological analysis following the 2016 World Health Organization (WHO) classification could be due to small samples because of histological heterogeneity. Objective: To assess whether the sample size sent...
Article
Full-text available
IDH (isocitrate dehydrogenase) gene mutations are present in most diffuse low-grade gliomas and define the clinico-pathological core of the respective morphologically defined entities. Conversely, according to the 2016 WHO classification, the majority of glioblastomas belong to the IDH-wildtype category, which is defined by exclusion. TERT (telomer...

Network

Cited By